Lung Cancer Surgery Market 2027 By Product, Procedure and Geography | The Insight Partners

Lung Cancer Surgery Market to 2027 - Global Analysis and Forecasts By Product (Surgical Instruments, Monitoring and Visualizing Systems); Procedure (Thoracotomy, Minimally Invasive Surgeries) and Geography

Report Code: TIPRE00006193 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION

Lung cancer surgery is used to perform to remove tumor along with some surrounding lung tissues. The surgery is depend on the type, location and stage of the lung cancer and other medical conditions. The surgery includes early stage non-small cell lung cancers and carcinoid tumors. There are four types of lung surgery namely, pneumonectomy, lobectomy, segmentectomy or wedge resection and sleeve resection.

MARKET DYNAMICS

The lung cancer surgery market is anticipated to grow in the forecast, owing to growing ageing population, increasing prevalence of lung cancer and rising awareness about advanced treatment methods. In addition, rising cases of lung cancer is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Lung Cancer Surgery Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of lung cancer surgery market with detailed market segmentation by product, procedure and geography. The global lung cancer surgery market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading lung cancer surgery market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global lung cancer surgery market is segmented on the basis product and procedure. Based on product, the market is segmented as, surgical instruments and monitoring and visualizing systems. On the basis of procedure, the market is bifurcated into thoracotomy and minimally invasive surgeries.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global lung cancer surgery market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The lung cancer surgery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting lung cancer surgery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the lung cancer surgery market in these regions.

MARKET PLAYERS

The reports cover key developments in the lung cancer surgery market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from lung cancer surgery market are anticipated to lucrative growth opportunities in the future with the rising demand for lung cancer surgery market in the global market. Below mentioned is the list of few companies engaged in the lung cancer surgery market.

The report also includes the profiles of key lung cancer surgery market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- KARL STORZ SE & Co. KG
- Olympus Corporation
- Ethicon Us, LLC (Johnson & Johnson)
- Accuray Incorporated
- Teleflex Incorporated
- AngioDynamics
- Scanlan International
- Intuitive Surgical
- TROKAMED GmbH
- Ackermann Instrumente GmbH

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Lung Cancer Surgery Market - By Product
1.3.2 Lung Cancer Surgery Market - By Procedure
1.3.3 Lung Cancer Surgery Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LUNG CANCER SURGERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LUNG CANCER SURGERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. LUNG CANCER SURGERY MARKET - GLOBAL MARKET ANALYSIS
6.1. LUNG CANCER SURGERY - GLOBAL MARKET OVERVIEW
6.2. LUNG CANCER SURGERY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. LUNG CANCER SURGERY MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. SURGICAL INSTRUMENTS
7.3.1. Overview
7.3.2. Surgical Instruments Market Forecast and Analysis
7.4. MONITORING AND VISUALIZING SYSTEMS
7.4.1. Overview
7.4.2. Monitoring and Visualizing Systems Market Forecast and Analysis
8. LUNG CANCER SURGERY MARKET - REVENUE AND FORECASTS TO 2027 - PROCEDURE
8.1. OVERVIEW
8.2. PROCEDURE MARKET FORECASTS AND ANALYSIS
8.3. THORACOTOMY
8.3.1. Overview
8.3.2. Thoracotomy Market Forecast and Analysis
8.4. MINIMALLY INVASIVE SURGERIES
8.4.1. Overview
8.4.2. Minimally Invasive Surgeries Market Forecast and Analysis
9. LUNG CANCER SURGERY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Lung Cancer Surgery Market Overview
9.1.2 North America Lung Cancer Surgery Market Forecasts and Analysis
9.1.3 North America Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.1.4 North America Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.1.5 North America Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.1.5.1 United States Lung Cancer Surgery Market
9.1.5.1.1 United States Lung Cancer Surgery Market by Product
9.1.5.1.2 United States Lung Cancer Surgery Market by Procedure
9.1.5.2 Canada Lung Cancer Surgery Market
9.1.5.2.1 Canada Lung Cancer Surgery Market by Product
9.1.5.2.2 Canada Lung Cancer Surgery Market by Procedure
9.1.5.3 Mexico Lung Cancer Surgery Market
9.1.5.3.1 Mexico Lung Cancer Surgery Market by Product
9.1.5.3.2 Mexico Lung Cancer Surgery Market by Procedure
9.2. EUROPE
9.2.1 Europe Lung Cancer Surgery Market Overview
9.2.2 Europe Lung Cancer Surgery Market Forecasts and Analysis
9.2.3 Europe Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.2.4 Europe Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.2.5 Europe Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Lung Cancer Surgery Market
9.2.5.1.1 Germany Lung Cancer Surgery Market by Product
9.2.5.1.2 Germany Lung Cancer Surgery Market by Procedure
9.2.5.2 France Lung Cancer Surgery Market
9.2.5.2.1 France Lung Cancer Surgery Market by Product
9.2.5.2.2 France Lung Cancer Surgery Market by Procedure
9.2.5.3 Italy Lung Cancer Surgery Market
9.2.5.3.1 Italy Lung Cancer Surgery Market by Product
9.2.5.3.2 Italy Lung Cancer Surgery Market by Procedure
9.2.5.4 Spain Lung Cancer Surgery Market
9.2.5.4.1 Spain Lung Cancer Surgery Market by Product
9.2.5.4.2 Spain Lung Cancer Surgery Market by Procedure
9.2.5.5 United Kingdom Lung Cancer Surgery Market
9.2.5.5.1 United Kingdom Lung Cancer Surgery Market by Product
9.2.5.5.2 United Kingdom Lung Cancer Surgery Market by Procedure
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Lung Cancer Surgery Market Overview
9.3.2 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis
9.3.3 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.3.5 Asia-Pacific Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Lung Cancer Surgery Market
9.3.5.1.1 Australia Lung Cancer Surgery Market by Product
9.3.5.1.2 Australia Lung Cancer Surgery Market by Procedure
9.3.5.2 China Lung Cancer Surgery Market
9.3.5.2.1 China Lung Cancer Surgery Market by Product
9.3.5.2.2 China Lung Cancer Surgery Market by Procedure
9.3.5.3 India Lung Cancer Surgery Market
9.3.5.3.1 India Lung Cancer Surgery Market by Product
9.3.5.3.2 India Lung Cancer Surgery Market by Procedure
9.3.5.4 Japan Lung Cancer Surgery Market
9.3.5.4.1 Japan Lung Cancer Surgery Market by Product
9.3.5.4.2 Japan Lung Cancer Surgery Market by Procedure
9.3.5.5 South Korea Lung Cancer Surgery Market
9.3.5.5.1 South Korea Lung Cancer Surgery Market by Product
9.3.5.5.2 South Korea Lung Cancer Surgery Market by Procedure
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Lung Cancer Surgery Market Overview
9.4.2 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis
9.4.3 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.4.5 Middle East and Africa Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Lung Cancer Surgery Market
9.4.5.1.1 South Africa Lung Cancer Surgery Market by Product
9.4.5.1.2 South Africa Lung Cancer Surgery Market by Procedure
9.4.5.2 Saudi Arabia Lung Cancer Surgery Market
9.4.5.2.1 Saudi Arabia Lung Cancer Surgery Market by Product
9.4.5.2.2 Saudi Arabia Lung Cancer Surgery Market by Procedure
9.4.5.3 U.A.E Lung Cancer Surgery Market
9.4.5.3.1 U.A.E Lung Cancer Surgery Market by Product
9.4.5.3.2 U.A.E Lung Cancer Surgery Market by Procedure
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Lung Cancer Surgery Market Overview
9.5.2 South and Central America Lung Cancer Surgery Market Forecasts and Analysis
9.5.3 South and Central America Lung Cancer Surgery Market Forecasts and Analysis - By Product
9.5.4 South and Central America Lung Cancer Surgery Market Forecasts and Analysis - By Procedure
9.5.5 South and Central America Lung Cancer Surgery Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Lung Cancer Surgery Market
9.5.5.1.1 Brazil Lung Cancer Surgery Market by Product
9.5.5.1.2 Brazil Lung Cancer Surgery Market by Procedure
9.5.5.2 Argentina Lung Cancer Surgery Market
9.5.5.2.1 Argentina Lung Cancer Surgery Market by Product
9.5.5.2.2 Argentina Lung Cancer Surgery Market by Procedure
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. LUNG CANCER SURGERY MARKET, KEY COMPANY PROFILES
11.1. KARL STORZ SE AND CO. KG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. OLYMPUS CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ETHICON US, LLC (JOHNSON AND JOHNSON)
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ACCURAY INCORPORATED
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. TELEFLEX INCORPORATED
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ANGIODYNAMICS
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SCANLAN INTERNATIONAL
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. INTUITIVE SURGICAL
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TROKAMED GMBH
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ACKERMANN INSTRUMENTE GMBH
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. KARL STORZ SE & Co. KG
2. Olympus Corporation
3. Ethicon Us, LLC (Johnson & Johnson)
4. Accuray Incorporated
5. Teleflex Incorporated
6. AngioDynamics
7. Scanlan International
8. Intuitive Surgical
9. TROKAMED GmbH
10. Ackermann Instrumente GmbH